GB0302446D0 - Screening for modulators of fat storage - Google Patents

Screening for modulators of fat storage

Info

Publication number
GB0302446D0
GB0302446D0 GBGB0302446.0A GB0302446A GB0302446D0 GB 0302446 D0 GB0302446 D0 GB 0302446D0 GB 0302446 A GB0302446 A GB 0302446A GB 0302446 D0 GB0302446 D0 GB 0302446D0
Authority
GB
United Kingdom
Prior art keywords
modulators
screening
fat storage
fat
storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0302446.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Priority to GBGB0302446.0A priority Critical patent/GB0302446D0/en
Publication of GB0302446D0 publication Critical patent/GB0302446D0/en
Priority to CA002515347A priority patent/CA2515347A1/en
Priority to JP2006502228A priority patent/JP2006518591A/en
Priority to PCT/GB2004/000413 priority patent/WO2004070347A2/en
Priority to AU2004209335A priority patent/AU2004209335A1/en
Priority to EP04707568A priority patent/EP1590674A2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
GBGB0302446.0A 2003-02-03 2003-02-03 Screening for modulators of fat storage Ceased GB0302446D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0302446.0A GB0302446D0 (en) 2003-02-03 2003-02-03 Screening for modulators of fat storage
CA002515347A CA2515347A1 (en) 2003-02-03 2004-02-03 Screening for modulators of fat storage
JP2006502228A JP2006518591A (en) 2003-02-03 2004-02-03 Storage fat modulator screening
PCT/GB2004/000413 WO2004070347A2 (en) 2003-02-03 2004-02-03 Screening for modulators of fat storage
AU2004209335A AU2004209335A1 (en) 2003-02-03 2004-02-03 Screening for modulators of fat storage
EP04707568A EP1590674A2 (en) 2003-02-03 2004-02-03 Screening for modulators of fat storage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0302446.0A GB0302446D0 (en) 2003-02-03 2003-02-03 Screening for modulators of fat storage

Publications (1)

Publication Number Publication Date
GB0302446D0 true GB0302446D0 (en) 2003-03-05

Family

ID=9952335

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0302446.0A Ceased GB0302446D0 (en) 2003-02-03 2003-02-03 Screening for modulators of fat storage

Country Status (6)

Country Link
EP (1) EP1590674A2 (en)
JP (1) JP2006518591A (en)
AU (1) AU2004209335A1 (en)
CA (1) CA2515347A1 (en)
GB (1) GB0302446D0 (en)
WO (1) WO2004070347A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691823B2 (en) * 2004-03-05 2010-04-06 University Of Massachusetts RIP140 regulation of glucose transport
JP2006090948A (en) * 2004-09-27 2006-04-06 Fuji Photo Film Co Ltd Screening method using biosensor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6266622B1 (en) * 1995-12-13 2001-07-24 Regents Of The University Of California Nuclear receptor ligands and ligand binding domains
JP4296608B2 (en) * 1997-08-27 2009-07-15 田辺三菱製薬株式会社 PPAR agonist and antagonist screening method
GB9917405D0 (en) * 1999-07-23 1999-09-22 Univ Dundee Methods of treatment and drug screening methods
WO2001033954A1 (en) * 1999-11-12 2001-05-17 Merck & Co., Inc. Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight
US20020004205A1 (en) * 2000-03-30 2002-01-10 Consler Thomas G. Method of investigating functional molecular interactions and reagents for use therein
JP2003125773A (en) * 2001-06-14 2003-05-07 Inst Natl De La Sante & De La Recherche Medical Screening method for nuclear receptor-modifying factor based on cofactor, and modifying factor related to the same

Also Published As

Publication number Publication date
WO2004070347A3 (en) 2004-12-16
WO2004070347A2 (en) 2004-08-19
CA2515347A1 (en) 2004-08-19
EP1590674A2 (en) 2005-11-02
JP2006518591A (en) 2006-08-17
AU2004209335A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
HK1080549A1 (en) Methods of screening for trpm4b modulators trpm4b
AU158373S (en) Set of containers
IL172030A0 (en) Hydrogel composition demonstrating phase separation
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
GB0318290D0 (en) Shared experience of media content
EP1682050A4 (en) Vertebral prosthesis
EP1677706A4 (en) Removable stent
EP1597349A4 (en) Methods of screening for trpm5 modulators
GB0309397D0 (en) Screening methods
IL179199A (en) Method of screening for modulators of wrn
GB0306575D0 (en) Modulators
GB0324428D0 (en) Modulator
SG112083A1 (en) Method for screening autoantigen
EP1626566A4 (en) Image processing for expressing gradation
GB0427301D0 (en) Bone support
GB0302446D0 (en) Screening for modulators of fat storage
GB2400348B (en) Support vessel
GB0318411D0 (en) Vessel
GB0501374D0 (en) Partitioning apparatus
GB0323260D0 (en) Containers for edible substances
GB2399559B (en) Construction of container
EP1743944A4 (en) Novel method of screening
AU2003206594A8 (en) Screening for modulators of pkng activity
GB0307280D0 (en) Screening of compounds
AU156010S (en) Set of hinged containers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)